154 related articles for article (PubMed ID: 8049630)
1. The epidemiology of tumor markers in breast cancer management: prognostic markers.
Page DL
Cancer Epidemiol Biomarkers Prev; 1994 Mar; 3(2):101-4. PubMed ID: 8049630
[No Abstract] [Full Text] [Related]
2. [Prognostic factors in breast cancer and their consequences for therapeutic decisions].
Graeff H; Jänicke F
Chirurg; 1992 Jun; 63(6):461-8. PubMed ID: 1643982
[No Abstract] [Full Text] [Related]
3. ["Prognostic factors" in breast cancer--1].
Brockmann B; Reitzig P
Z Arztl Fortbild (Jena); 1994 Feb; 88(2):111-4. PubMed ID: 8147017
[No Abstract] [Full Text] [Related]
4. [Role of prognostic factors in evaluation of survival in breast cancer].
Popârlan T; Muscă S
Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):147-51. PubMed ID: 20509292
[TBL] [Abstract][Full Text] [Related]
5. [Bel-2 as a prognostic factor of breast cancers].
Watanabe K; Kawabata K; Ozaki S; Fujita H; Kojima Y; Tsuda H
Nihon Rinsho; 2000 Apr; 58 Suppl():423-8. PubMed ID: 11026028
[No Abstract] [Full Text] [Related]
6. [Prognostic factors in breast cancer].
Jonat W; Eidtmann H; Friedrichs K
Gynakologe; 1994 Feb; 27(1):37-44. PubMed ID: 8168736
[No Abstract] [Full Text] [Related]
7. Proliferative activity in primary breast carcinomas is a salient prognostic factor.
Michels JJ; Marnay J; Delozier T; Denoux Y; Chasle J
Cancer; 2004 Feb; 100(3):455-64. PubMed ID: 14745860
[TBL] [Abstract][Full Text] [Related]
8. [Tumor biology-oriented treatment concepts in gynecologic oncology].
Graeff H
Geburtshilfe Frauenheilkd; 1995 Mar; 55(3):M27-31. PubMed ID: 7665053
[No Abstract] [Full Text] [Related]
9. HER-2 expression and cell proliferation: prognostic markers in patients with node-negative breast cancer.
Volpi A; Nanni O; De Paola F; Granato AM; Mangia A; Monti F; Schittulli F; De Lena M; Scarpi E; Rosetti P; Monti M; Gianni L; Amadori D; Paradiso A
J Clin Oncol; 2003 Jul; 21(14):2708-12. PubMed ID: 12860948
[TBL] [Abstract][Full Text] [Related]
10. [Strategies for management of axillary lymph nodes in breast cancer. Point of view of the Institut Bergonié. ].
de Mascarel I; MacGrogan G
Ann Pathol; 2003 Dec; 23(6):518-33. PubMed ID: 15094590
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for breast cancer and their use in the clinical setting.
Kapoor A; Vogel VG
Expert Rev Anticancer Ther; 2005 Apr; 5(2):269-81. PubMed ID: 15877524
[TBL] [Abstract][Full Text] [Related]
12. [Recent prognostic factors for breast cancer].
Ikeda T
Gan To Kagaku Ryoho; 1997 Apr; 24(6):635-43. PubMed ID: 9126298
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of prostate-specific antigen does not correlate to other prognostic factors in breast cancer.
Heyl W; Wolff JM; Biesterfeld S; Schröder W; Zitzelsberger D; Jakse G; Rath W
Anticancer Res; 1999; 19(4A):2563-5. PubMed ID: 10470195
[TBL] [Abstract][Full Text] [Related]
14. Improved tumor staging in colorectal cancer.
Lindblom A
N Engl J Med; 1998 Jul; 339(4):264-5. PubMed ID: 9673307
[No Abstract] [Full Text] [Related]
15. [Cathepsin D as a prognostic marker in breast cancer].
Asculai E; Gopas J; Cohen Y
Harefuah; 1996 Jun; 130(11):787-90. PubMed ID: 8794687
[No Abstract] [Full Text] [Related]
16. [Prognostic tissue criteria of pT1-2, pN0-1, M0 cancers of the breast with a low or moderate metastatic potential].
Bolla M; Pasquier D; Chédin M; Winckel P; Mousseau M; Berland E; Salvat J; Panh MH; Payan R
Bull Cancer; 1996 Dec; 83(12):1061. PubMed ID: 9116376
[No Abstract] [Full Text] [Related]
17. [Clinicopathological and biological features of breast cancer in young females and their relationship with prognosis].
Meng J; Lang RG; Fan Y; Fu L
Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):284-8. PubMed ID: 17760256
[TBL] [Abstract][Full Text] [Related]
18. Molecular prognostic factors for breast cancer metastasis and survival.
Esteva FJ; Sahin AA; Cristofanilli M; Arun B; Hortobagyi GN
Semin Radiat Oncol; 2002 Oct; 12(4):319-28. PubMed ID: 12382190
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma.
Yang Q; Yoshimura G; Suzuma T; Tamaki T; Umemura T; Nakamura M; Nakamura Y; Wang X; Mori I; Sakurai T; Kakudo K
Clin Cancer Res; 2001 Dec; 7(12):3869-73. PubMed ID: 11751477
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic factors in breast cancer with contralateral supraclavicular or axillary lymphatic metastases].
Muñoz-González D; Mora-Tizcareño A; Ramírez-Ugalde MT; Pérez-Sánchez M; Sánchez-Valdivieso E; Gómez-Ruiz C; Zeichner-Gancz I
Rev Invest Clin; 1998; 50(1):25-30. PubMed ID: 9608786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
